Developing and deploying genomics technologies in support of cancer and life sciences research.

Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC) is an international leader in genomics, bioinformatics and proteomics for precision medicine. By developing and deploying cutting-edge genome sequencing, computational and analytical technology, we are creating novel strategies to prevent and diagnose cancers and other genomic diseases, uncovering new therapeutic targets and helping the world realize the social and economic benefits of genome science. 

Our Focus

Translating genome science to help diagnose and treat cancers and other diseases 

The GSC fosters close collaborations between scientists and clinicians, allowing for direct translational research. Through the Personalized OncoGenomics (POG) program, the GSC deploys whole genome sequencing technology to influence therapeutic and management strategies for late-stage cancer patients in real time. The GSC is certified by the College of American Pathologists (CAP) and the Diagnostic Accreditation Program (DAP) to perform clinical genomic panel testing. It is ISO 27001 certified for information security management.

Questions?

Fill out a contact form or speak with one of our Platform Leaders directly. 

Celebrating 20 years of discovery

cover-gsc20-booklet

In commemoration of our 20th anniversary, this booklet highlights the scientific discoveries and innovations born from the GSC. Learn about our past accomplishments, our current areas of research and our amazing team of Principal Investigators who use cutting-edge molecular and computational biology approaches to study problems relevant to health and disease. It also profiles the staff, partners, collaborators and alumni that spoke out our 20th Anniversary Symposium on November 21, 2019.

News

Directors & Platform Leaders

Recent Publications

Back to top